Astrid Konrad

Astrid Konrad

UNVERIFIED PROFILE

Are you Astrid Konrad?   Register this Author

Register author
Astrid Konrad

Astrid Konrad

Publications by authors named "Astrid Konrad"

Are you Astrid Konrad?   Register this Author

22Publications

600Reads

18Profile Views

Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells.

Eur J Immunol 2009 Nov;39(11):3134-46

Division of Gastroenterology and Hepatology, Department of Medicine, Birmingham, AL 35294-0007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200939052DOI Listing
November 2009

Pharmacogenetics of Crohn's disease.

Pharmacogenomics 2008 Jul;9(7):881-93

University of Munich, Department of Internal Medicine II, Campus Grosshadern, Marchioninistr. 15, D-81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14622416.9.7.881DOI Listing
July 2008

CXCL16 is a surrogate marker of inflammatory bowel disease.

Scand J Gastroenterol 2008 Mar;43(3):283-8

Department of Internal Medicine II, University of Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365520701679249DOI Listing
March 2008

Resistin is an inflammatory marker of inflammatory bowel disease in humans.

Eur J Gastroenterol Hepatol 2007 Dec;19(12):1070-4

Department of Internal Medicine II, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0b013e3282f16251DOI Listing
December 2007

Tight mucosal compartmentation of the murine immune response to antigens of the enteric microbiota.

Gastroenterology 2006 Jun;130(7):2050-9

Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2006.02.055DOI Listing
June 2006

Generation of antigen-specific, Foxp3-expressing CD4+ regulatory T cells by inhibition of APC proteosome function.

J Immunol 2005 Mar;174(5):2787-95

Division of Gastroenterology and Hepatology, Department of Medicine, University of Alabama, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.174.5.2787DOI Listing
March 2005

Ameliorative effect of IDS 30, a stinging nettle leaf extract, on chronic colitis.

Int J Colorectal Dis 2005 Jan 25;20(1):9-17. Epub 2004 Aug 25.

Division of Gastroenterology, Inselspital, University Hospital, University of Bern, Freiburgstrasse, 3010 Berne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-004-0619-zDOI Listing
January 2005

Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease.

Gastroenterology 2004 Oct;127(4):1076-84

Division of Gastroenterology, Inselspital, University of Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2004.07.056DOI Listing
October 2004

Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease.

Inflamm Bowel Dis 2004 Mar;10(2):97-105

Division of Gastroenterology, Inselspital, University of Bern, Freiburgstrasse, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00054725-200403000-00006DOI Listing
March 2004

Gene disruption and immunity in experimental colitis.

Inflamm Bowel Dis 2004 Feb;10 Suppl 1:S25-8

Division of Gastroenterology, University of Alabama at Birmingham, Birmingham, Alabama 35294-0007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00054725-200402001-00005DOI Listing
February 2004

Probiotics and immune regulation of inflammatory bowel diseases.

Curr Drug Targets Inflamm Allergy 2003 Jun;2(2):145-54

Division of Gastroenterology and Hepatology, The University of Alabama at Birmingham, Birmingham, AL 35294-0007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568010033484278DOI Listing
June 2003

[A therapeutic option for type-2 diabetes. The incretion hormone GLP-1].

Pharm Unserer Zeit 2002 ;31(3):294-9

Medizinische Klinik II, Klinikum Grosshadern Ludwig-Maximilians-Universität Marchioninistr. 15, 81377 München.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/1615-1003(200205)31:3<294::AID-PAUZ294>3.0.CO;2-1DOI Listing
July 2002